A Billion Dollars of Salmon, Sold for Pennies: The Hard Math of Land-Based Aquaculture in 2026

**The pitch is irresistible: grow seafood on American soil, free of imports, disease, and ocean pollution, close to the people who eat it. Investors have poured hundreds of millions into land-based salmon and indoor shrimp on exactly that promise. The results read like a casualty list. A flagship Florida salmon plant that raised close to a billion dollars is being taken private at roughly eight cents a share. A genetically engineered salmon company auctioned a half-finished farm's equipment for a fraction of what it spent. A six-year, state-funded shrimp venture closed without ever building its commercial plant. For anyone weighing a recirculating aquaculture facility, the sustainability story and the unit economics are pulling in opposite directions, and the gap between them is where the capital disappears.**

There is a version of this story that sells. The United States runs a seafood trade deficit of more than twenty billion dollars, imports a large majority of the seafood it eats, and depends on foreign aquaculture for much of it. Shrimp is the country's most-consumed seafood, salmon its second, and almost all of both arrive from abroad. Against that backdrop, a domestic, biosecure, sustainable, land-based alternative sounds less like a gamble than an inevitability, and the federal government has signaled it agrees, with executive orders pushing to streamline aquaculture permitting and restore American seafood competitiveness.

Then there is the version that pencils, and it is a far shorter document. Recirculating aquaculture systems, the technology behind nearly all of these projects, are among the most capital-intensive and operationally unforgiving facilities in food production. The sector is now living through the same hype-and-reckoning cycle that flattened indoor vertical farming, and for the same reasons. This is an assessment of both, the powerful narrative and the brutal arithmetic, written for the only question a lender ultimately asks: will this facility generate enough cash to service its debt?

Before going further, the headline justification deserves scrutiny, because the entire import-substitution case leans on a statistic that is shakier than it appears. The widely repeated claim is that the United States imports seventy to ninety percent of its seafood. Federal sources cite figures across that range, and one recent executive order put the imported share of the edible supply above ninety percent.

The number is misleading in a specific, well-documented way. A landmark study in the Proceedings of the National Academy of Sciences found that the true import-reliance figure is closer to thirty-five to thirty-eight percent once you correct for a large volume of fish that is caught in American waters, shipped abroad for processing, and then re-imported. Counting that fish as a foreign import inflates the dependence figure dramatically. The ninety-percent framing, the researchers noted, has been deployed to justify protectionist policy, and it papers over the fact that a meaningful share of so-called imports is American fish making a round trip.

This matters for a feasibility analysis because it reframes the size of the prize. If the genuine, addressable import-substitution opportunity is a third of consumption rather than nine-tenths of it, the market a new domestic facility can realistically capture, at a price consumers will pay, is far smaller than the promotional decks assume. The narrative is not false. It is inflated, and a project built on the inflated version is mispriced from the first page.

The most efficient way to understand the risk is to look at what has actually happened to the flagship projects, because the record is unusually clear and unusually grim.

Atlantic Sapphire, the most prominent land-based salmon venture in the country, built a vast facility in Homestead, Florida, on the promise of eventually producing well over a hundred thousand tons of salmon a year. The reality has been a cascade of mass fish-mortality events, water-system and temperature-control failures, emergency harvests, and losses that grew rather than shrank. The company lost roughly fifty-five million dollars in 2020, around a hundred and thirty-four million in 2023, and more than a hundred and ninety million in 2025. It survived only through a series of dilutive rescue financings, and by early 2026 it needed an emergency bridge loan simply to avoid insolvency. By the spring of 2026 its major shareholders were taking it private at roughly eight cents a share and delisting it, squeezing out the minority investors who had funded the dream. The plant grows salmon. The business never worked.

AquaBounty, which pioneered genetically engineered salmon, tells a parallel story in the language of securities filings. It paused construction of a large Ohio farm after spending around a hundred and forty-five million dollars, having completed perhaps thirty percent of a facility that would have needed roughly four hundred million more to finish. It then sold its Indiana farm for about nine million dollars, sold its Canadian operations and its engineered-salmon intellectual property for under two million, auctioned the Ohio equipment for a little over two million, and ceased fish farming entirely. Its 2024 net loss approached a hundred and fifty million dollars, most of it asset write-downs, and it entered 2026 with roughly half a million dollars of cash and substantial doubt about its ability to continue.

Nordic Aquafarms spent tens of millions pursuing two coastal projects, a five-hundred-million-dollar farm in Maine and a six-hundred-and-fifty-million-dollar facility in California, and abandoned both, the first after a land-title ruling dissolved its site control and the second after years of permitting effort failed to attract the capital to build. tru Shrimp, a Minnesota indoor-shrimp venture, took a five-and-a-half-million-dollar state loan in 2018, repeatedly delayed its commercial plant, never built it, and closed its research facility in late 2025, pivoting to pet treats. NaturalShrimp, a Texas indoor-shrimp company, went into receivership and saw its assets sold to its secured lenders, with more than twenty-five million dollars of carrying value extinguishing only a portion of its debt.

The pattern across all of them is not bad luck. It is a technology and a cost structure that punish optimism, and a procession of sponsors who learned that after the capital was committed rather than before.

None of this should surprise anyone who watched indoor agriculture over the same period, because land-based aquaculture is running the identical script. Vertical farming raised roughly eight billion dollars globally between 2018 and 2022 on a nearly identical promise of local, sustainable, climate-controlled production, and has raised under a billion since. AppHarvest raised more than seven hundred million dollars and went bankrupt. Bowery Farming raised seven hundred million, reached a valuation of more than two billion, and shut down. Plenty raised close to a billion from sophisticated backers and filed for bankruptcy with its valuation down more than ninety-nine percent. By one industry count, fourteen controlled-environment-agriculture companies went bankrupt in 2025 alone.

The diagnosis that emerged from that wreckage applies word for word to aquaculture. The failed companies were technology companies first and farming companies second. They scaled before their unit economics worked. They replaced a free natural input, sunlight in one case, ocean in the other, with expensive engineered substitutes, electricity and pumps and water treatment, and discovered that the substitute cost more than the product could bear. And the survivors shared a profile: spending discipline, secured buyers before construction, right-sized facilities rather than monuments, and management that had actually operated this kind of plant before. A lender evaluating an aquaculture project in 2026 is, in effect, looking at the vertical-farming collapse with the species changed. The cautionary tale is not an analogy. It is the same tale.

Strip away the narrative and the economics come down to a few stubborn numbers, and they are worth stating plainly because they are the heart of any honest feasibility study.

Start with capital cost. Around 2020 the industry believed it could build land-based salmon capacity for roughly fifteen thousand dollars per ton of annual output. Now that several large farms have actually been built, the participants concede that real-world construction costs more than thirty thousand dollars per ton, more than double the original benchmark. A U.S. project estimate puts the figure at over thirty-three thousand dollars per ton at the low end. That escalation alone has invalidated a generation of business plans that were underwritten on the cheaper assumption.

Then operating cost. In land-based salmon, feed is the single largest operating line, running close to half of total operating expenses, and energy, for pumping, heating and cooling, oxygenation, and water treatment, is the next dominant cost. Conventional ocean net-pen salmon, by contrast, gets its water movement and temperature regulation from the sea at no cost, which is precisely why net-pen production is cost-efficient and land-based production struggles to match it. The result shows up in the production figures: recirculating salmon has cost more than sixty dollars per kilogram to produce at troubled farms, against an industry benchmark closer to forty, because most facilities reach only a fraction of their designed capacity for years. One veteran operator's math is brutal in its clarity. Replacing U.S. salmon imports with land-based production would require something like twenty-six billion dollars of investment, and earning a normal return on that capital would demand a net profit per kilogram three to five times what most producers actually earn today.

Shrimp is worse, because the price it must beat is lower. Asian pond shrimp is produced at a cost of roughly two and a half to under five dollars per kilogram, and imported shrimp lands cheaply enough that a U.S. indoor facility, carrying its enormous capital and energy burden, cannot come close on price. The only defensible position is a premium, fresh, local, biosecure niche, and that niche is small and hard to hold once a facility scales up and has real volume to move. The string of indoor-shrimp closures over the past year, attributed across the industry to high capital costs, technical difficulty, rising energy bills, and the near impossibility of competing with imported pond shrimp, is the predictable consequence.

Finally, biology is a balance-sheet risk in this business in a way it is not in most. A single system failure, a loss of oxygen, a disease outbreak, an off-flavor event that forces fish into prolonged depuration and weight loss, can wipe out a cohort and a year of revenue. Shrimp diseases such as early mortality syndrome and white spot have repeatedly capped global supply. Recirculating fish accumulate compounds called geosmin and MIB that taint the flesh and require a fasting depuration period that itself reduces saleable weight. Managing these risks demands redundancy, segregated systems and backup power and oxygen, which is sound practice and also another layer of capital cost. The plants that skip it are gambling the entire enterprise on nothing going wrong, and in this sector something usually does.

There is a particular failure mode that deserves its own attention, because it has sunk even well-capitalized projects and it is routinely understated in projections. Recirculating facilities almost never reach their nameplate capacity on schedule. They underperform for years, as operators learn the biology of a specific system, fight mortality and off-flavor, and discover that the difference between a pilot and a commercial plant is enormous.

This matters because the per-kilogram economics depend entirely on volume. A plant designed for ten thousand tons that produces three thousand is not running at a discount. It is running at a loss, because the capital and fixed costs were sized for the larger number and do not shrink to match the smaller one. The realized cost per kilogram balloons, the projected margin evaporates, and the facility burns cash precisely when its investors expected it to start earning. Atlantic Sapphire never reached steady-state production through its first phase. A feasibility analysis that accepts a sponsor's smooth ramp-up curve, rather than modeling years of underperformance as the base case, is not analysis. It is stenography.

For the projects that remain, the question becomes which capital is available and what it requires, and here the public-program landscape is genuinely relevant, with two important constraints.

USDA's Business and Industry guaranteed loan program is open to aquaculture, and notably so. While the program restricts most primary agricultural production, it carves out aquaculture operations as broadly eligible, and in early 2026 it raised its guarantee to eighty-five percent for loans under five million dollars. That transfers most of a lender's default risk to the government and is what can persuade a bank to finance a specialized facility it would otherwise decline. But there is a caution that bears directly on part of this sector. In an action extended in April 2026, USDA paused loan-note guarantees for controlled environment agriculture, a category that explicitly includes aquaponics, the salmon-and-greens model that one of the few operating success stories uses. A project that combines fish with hydroponic plants has to confirm whether it falls inside that freeze before counting on a USDA guarantee, and the freeze itself is a signal of federal wariness toward this whole family of capital-intensive, enclosed-production lending.

The Small Business Administration is the other channel. Its combined 7(a) and 504 lending limit rose to ten million dollars in 2026, which expands what a borrower can assemble for a fixed-asset-heavy project. But ten million dollars is a rounding error against the hundred-and-fifty-million to five-hundred-million-dollar capital cost of a flagship land-based salmon farm, which means the large projects are not SBA-financeable at all. The SBA route fits a small, modular indoor-shrimp operation or a niche finfish facility, not an industrial-scale plant. Farm Service Agency loans, which treat aquaculture as an eligible agricultural enterprise, and conventional or specialized lenders round out the options.

Private capital, meanwhile, has done what it did to vertical farming. Aquaculture venture funding fell sharply from its 2023 peak, and the broader agrifoodtech market has contracted for several consecutive years, with the money that remains flowing toward proven unit economics and operating teams rather than concepts and spreadsheets. The capital-intensive nature of these projects pushes them beyond ordinary venture appetite and toward corporate, government, and bank financing, which is exactly the financing that now demands rigorous proof.

A lender's last line of defense is the collateral, and in this sector that defense is unusually weak, which the failures have demonstrated with painful precision. A purpose-built recirculating aquaculture facility is highly specialized and not easily repurposed, so when a project fails, the recovery is brutal. Nordic Aquafarms' abandoned five-hundred-million-dollar Maine project left behind land listed for around two million dollars. AquaBounty spent a hundred and forty-five million on its Ohio farm and auctioned the equipment for roughly two million. NaturalShrimp's assets, carried at more than twenty-five million dollars, extinguished only a portion of the debt secured against them.

The lesson for underwriting is that the asset offers little protection, which throws the entire weight of the credit decision onto the cash flow and the sponsor's equity. A lender should haircut the collateral severely, weight in a heavy premium for first-of-a-kind technology risk, require deep sponsor equity and completion guarantees, and recognize that if the projections are wrong, there is no comfortable exit through liquidation. This is the opposite of, say, a multifamily building or a warehouse, where the real estate retains value regardless of the operator. A failed fish plant is mostly tanks and pipes that no one else wants.

None of this means a land-based aquaculture facility cannot succeed. It means the bar is specific and high, and the projects that clear it look nothing like the casualty list. The lone widely cited operating success in U.S. land-based salmon is instructive precisely because it is the inverse of the failures: it is small rather than monumental, it pre-sells its entire output within a regional radius, it grew gradually rather than betting everything on an unproven full-scale plant, and it is funded by patient capital rather than the expectation of a quick return. Tellingly, even that operator declines to disclose its profitability, which counsels treating "profitable" claims in this sector with care.

A financeable project, then, is one that uses proven technology operated by a team that has actually run this kind of facility, not a first-of-a-kind design backed by enthusiasm. It models years of below-nameplate production as its base case rather than assuming a clean ramp-up. It prices its output conservatively against the landed cost of imports and the cost of net-pen or pond competition, and proceeds only if it still pencils against those benchmarks rather than against a hoped-for premium. It builds in biosecurity and redundancy. It secures committed buyers before it breaks ground. It carries enough working capital to fund the multi-year losses that nearly every facility in this sector absorbs. And it occupies a defensible niche rather than promising to single-handedly replace a flood of cheap imports.

Those requirements are not obstacles invented to discourage good projects. They are the distilled lessons of well over a billion dollars of destroyed capital, and they are the difference between the rare operator quietly selling out its harvest and the flagship names being delisted at pennies on the share. The narrative of domestic, sustainable seafood is genuine, and the trade deficit it points to is real even after the import figure is corrected. But a narrative does not service debt. Cash flow does, and in land-based aquaculture the cash flow has been savagely hard to produce.

The opportunity in domestic aquaculture is easy to feel and hard to bank. Every force in the narrative, import dependence, sustainability, biosecurity, consumer demand for fresh and local seafood, points toward building. Every force in the arithmetic, the doubled capital costs, the energy burden, the production costs that exceed import prices, the ramp-up that never arrives on time, the biology that can erase a year in a week, and the collateral that recovers pennies, points toward caution. The two are not symmetric, and the casualty list shows which one tends to win.

For a sponsor, the work that separates the survivors from the statistics is the same work the failures skipped. It means proving the technology, proving the team, proving the demand, and proving the cash flow against conservative assumptions and the hard benchmark of cheap imported product, before committing a dollar of capital. The seafood is real. The losses have been real. The discipline of telling, honestly, which of these facilities can actually service its debt is the entire purpose of a feasibility study, and in a sector that has turned close to a billion dollars of salmon into an eight-cent share price, it has rarely mattered more.

*This assessment reflects publicly available information as of June 2026, including USDA Economic Research Service and Rural Development materials, NOAA Fisheries data, U.S. Small Business Administration notices, Securities and Exchange Commission filings, peer-reviewed research, university extension economics, and reputable industry reporting. Company statuses and program terms described here are changing and should be reconfirmed as of any application or investment date. Import-dependence and market-size figures vary widely by source and methodology. This material is provided for general information and is not financial, legal, or investment advice. Feasibility conclusions for any specific project depend on its species, technology, location, energy market, offtake, and capital structure, and require a tailored study.*